Omnipaque recalls

Omnipaque products have been recalled 3 times, most recently on 15 Apr 2026. The recalling company is usually GE Healthcare Ireland. The most common reason is particulate matter.

Total recalls3since 2018

Last 12 months2reported

Class I00% of total

Ongoing2latest 15 Apr 2026

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 0 0Oct 0 0 0Jan '26 0 0 2Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why omnipaque is recalled

Particulate Matter3100%

Companies

Product types

Injectable & IV Drugs3100%

By year

2026267%
2018133%

Ongoing omnipaque recalls

2 active

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL 7%) recalledOmnipaque	GE Healthcare Ireland	Particulate Matter	Nationwide
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL 7%) recalledOmnipaque	GE Healthcare Ireland	Particulate Matter	Nationwide

All omnipaque recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 300 mg/mL 7%) recalledOmnipaque	GE Healthcare Ireland	Particulate Matter	Nationwide
15 Apr 2026Drug	CLASS II	GE Healthcare Omnipaque (iohexol) Injection, 350 mg/mL 7%) recalledOmnipaque	GE Healthcare Ireland	Particulate Matter	Nationwide
26 Dec 2018Drug	CLASS II	Omnipaque (iohexol) Injection, 180mgI/mL Single-Dose Vial recalledOmnipaque	GE Healthcare Inc. Life Sciences	Particulate Matter	TN

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.